Tender topic · UNSPSC segment 51
Drugs and pharmaceuticals: open federal tenders
1 open now, of 65 tenders in this topic since 2022. Every topic
CanadaBuys tender notices published since Aug 2022; open as of October 12, 2026. Source: Public Services and Procurement Canada, CanadaBuys open data.
Open now
Closing soonest first.
| Closes | Tender | Delivery |
|---|---|---|
| Nov 10, 202628 days | PralidoximeDepartment of National Defence (DND) | Anywhere in Canada, Outside Canada |
Who wins these
Suppliers with the most award value in this topic.
| Supplier | Awards | Total |
|---|---|---|
| Merck Canada Inc. | 4 | $370M |
| Moderna Biopharma Canada Corporation | 1 | $361M |
| Pfizer Canada ULC | 2 | $258M |
| GlaxoSmithKline Inc. | 7 | $128M |
| Emergent Product Development Gaithersburg Inc | 2 | $87.5M |
| Emergent BioSolutions Canada Inc. | 5 | $85.4M |
| Sanofi Pasteur Limited/Sanofi Pasteur Limitee | 3 | $79.6M |
| Elusys Therapeutics, Incorporated | 1 | $45.7M |
| Natco Pharma (Canada) Inc. | 3 | $23.2M |
| HEYL Chem.-pharm. Fabrik GmbH & Co. KG | 2 | $19.9M |
| Boehringer Ingelheim Animal Health | 1 | $18.1M |
| Indivior UK Ltd | 1 | $13.6M |
| Emergent BioDefense Operations Lansing | 1 | $12.1M |
| McKesson Canada | 1 | $9.6M |
| Biogénesis Bagó S.A. | 1 | $9.4M |
| Innomar Strategies Inc | 1 | $6.2M |
| Sandoz Canada Inc. | 3 | $5.7M |
| Octapharma Canada Inc | 1 | $4.6M |
| Pharmascience Inc. | 4 | $4.3M |
| Apotex Inc. | 2 | $4M |
Recent awards
| Awarded | Supplier | What | Buyer | Value |
|---|---|---|---|---|
| Aug 2026 | Emergent BioSolutions Canada Inc. | SO - Naloxone Nasal Spray - Emergent BioSolutions Canada Inc | Royal Canadian Mounted Police (RCMP) | $3,000,000 |
| Apr 2026 | McKesson Canada Corporation | 21120-268734 Cystic Fibrosis Medications NISO | Correctional Service of Canada (CSC) | $4,000,000 |
| Apr 2026 | PRAXES Medical Group | K4E21-260484 REMOTE MEDICAL HEALTH CARE SUPPORT WITH MEDICAL SUPPLY KITS | Department of the Environment (ECCC ) | $79,147 |
| Apr 2026 | GlaxoSmithKline Inc. | Hepatitis B Vaccines GSK | Department of Public Works and Government Services (PSPC) | $9,462,827 |
| Apr 2026 | Merck Canada Inc. | Hepatitis B Vaccines Merck | Department of Public Works and Government Services (PSPC) | $3,855,797 |
| Mar 2026 | GlaxoSmithKline Inc. | Contract (GSK) - Supply Pertussis-containing vaccines | Department of National Defence (DND); Correctional Service of Canada (CSC); Department of Health (HC) | $29,400,277 |
| Mar 2026 | Sanofi Pasteur Limited/Sanofi Pasteur Limitee | Contract (Sanofi) - Supply Pertussis-containing vaccines | Correctional Service of Canada (CSC); Department of Health (HC); Department of National Defence (DND) | $37,781,553 |
| Feb 2026 | Emergent Product Development Gaithersburg Inc | ACAM2000-2nd Generation Smallpox Vaccine | Public Health Agency of Canada (PHAC) | $34,175,344 |
| Feb 2026 | Emergent BioDefense Operations Lansing | Tembexa (brincidofovir) Smallpox antiviral | Public Health Agency of Canada (PHAC) | $12,148,810 |
| Feb 2026 | GlaxoSmithKline Inc. | Meningococcal B Vaccine 2026 - GSK | Department of Public Works and Government Services (PSPC) | $3,147,955 |
| Oct 2025 | Not named here | Public Health Agency of Canada (PHAC) | $486,840 | |
| Jun 2025 | Moderna Biopharma Canada Corporation | COVID-19 Vaccines | Department of Public Works and Government Services (PSPC) | $360,542,980 |
| Jun 2025 | Pfizer Canada ULC | COVID-19 Vaccines | Department of Public Works and Government Services (PSPC) | $218,379,736 |
| May 2025 | Emergent BioSolutions Canada | 6D012-247322 - Vendor Managed - 3 Streams | Public Health Agency of Canada (PHAC) | $351,000 |
| May 2025 | Biogénesis Bagó S.A. | Foot and Mouth Disease Vaccine Bank | Canadian Food Inspection Agency (CFIA) | $9,397,000 |
| May 2025 | Boehringer Ingelheim Animal Health | Foot and Mouth Disease Vaccine Bank | Canadian Food Inspection Agency (CFIA) | $18,112,500 |
| Apr 2025 | Innomar Strategies Inc | Innomar Strategies Standing Offer | Correctional Service of Canada (CSC) | $6,180,000 |
| Apr 2025 | Sandoz Canada Inc. | Amend 002 Contract Oseltamivir capsules | Department of Public Works and Government Services (PSPC) | $2,678,750 |
| Mar 2025 | Not named here | The tender | Department of National Defence (DND) | $519,826 |
| Feb 2025 | Grifols Canada Ltd | Rabies Immunoglobulin (RIG) | Department of Public Works and Government Services (PSPC) | $396,724 |
| Dec 2024 | Providence Health Care Society | 21807-240025-001-PH - HIV Drugs | Correctional Service of Canada (CSC) | $1,700,000 |
| Oct 2024 | HEYL Chem.-pharm. Fabrik GmbH & Co. KG | Amend 003 - DMPS Capsules and Ampoules | Department of National Defence (DND) | $17,794,309 |
| Sep 2024 | Indivior UK Ltd | Buprenorphine | Correctional Service of Canada (CSC) | $13,640,000 |
| Sep 2024 | Chiron Compounding Pharmacy Inc. | Sedative and Reversal Drugs for Deer | Canadian Food Inspection Agency (CFIA) | $27,867 |
| Sep 2024 | Fresenius Kabi Canada Ltd | Calcium Gluconate | Public Health Agency of Canada (PHAC) | $429,720 |
CanadaBuys award notices since Aug 2022. They overlap the Treasury Board contract figures and are never added to them. Source: CanadaBuys open data, October 12, 2026.